Mistletoe and the Emerging Future of Integrative Oncology (2023)
With 100 years of continuous use and backed by 250 randomized studies , it is the most studied integrative oncology therapy in the world - and utilized in upward of 60% to 80% of patients in Europe. Dr. Nasha Winters, coauthor of “ Mistletoe and the Emerging Future of Integrative Oncology ,” reviews some of the benefits of this ancient herb in the modern world of oncology. Winters is herself a cancer survivor, so this topic is close to her heart. “I'm coming on 30 years out of a death sentence, a terminal cancer diagnosis,” she says, “and still to this day get met with so much resistance to what I've learned for myself, and for thousands, if not tens of thousands, of other patients directly, as well as way more than that, indirectly, through the training of their physicians ... My crazy controversy is that I focus more on the human organism and the health of that terrain versus the condition, the disease or the label that overlays that person.” Update: Johns Hopk...